金斯瑞生物科技2023中期报告

23572549505152545658 (i)(ii)CDMO(iii)(iv) 21 1006,414 CDMOCGTCDMO (cilta-cel)JanssenBiotech,Inc.MMT 1531 97927 2023004 4th Floor, Harbour Place103 South Church Street, George TownP.O. Box 10240, Grand Cayman KY1-1002Cayman Islands 383 Madison AvenueNew YorkNY 10017USA 28 88 24840 www.genscript.comwww.genscriptprobio.comwww.legendbiotech.com www.bestzyme.com Harneys Services (Cayman) Limited4th Floor, Harbour Place103 South Church StreetGeorge TownP.O. Box 10240, Grand Cayman KY1-1002Cayman Islands — 1548 183171712–1716 •391.3309.626.4%281.8247.713.8%109.561.976.9% •175.0168.53.9%134.7126.26.7%41.445.18.2% •245.8233.6 162.0134.833.633.21.2%195.7168.2 •93.6135.5 2023006 (2)(i)(ii)(iii)(iv)(v)(vi)(vii) (3)3 391.3309.626.4%175.0168.53.9%93.6135.5 (i)(ii)(iii)(iv)(v)50.8%16.5%4.6%28.0%0.1% 2023008 1. 203.0176.015.3%110.5101.29.2%57.5%54.4%39.233.616.7% (i)(ii) 2. 65.162.73.8%19.523.918.4%38.1%30.0%6.2 (i)(ii)(i)(ii) 3. 18.216.88.3%7.242.9%39.4%0.3 (i)(ii) 4. 109.762.076.9%CARVYKTI 205.9168.0168.8141.5(i)cilta-cel3(ii)38.041.646.825.1CARVYKTI67.216.7 2023010 391.3309.626.4%(i)(ii)FDACARVYKTI 168.53.9%175.02.3% 86.96.3%81.4CARVYKIT6.2% 79.633.8%106.5(i)(ii)(iii)42.4% 177.616.7%207.3(i)(ii)(iii)16.5% (i)14.4162520,809,850(ii)10,000,000300.020.0 200.010,000,000 85.8 Probio Technology LimitedProbio CaymanProbio Cayman300,000,000Probio Cayman AProbio CaymanA189,393,939Probio CaymanProbioProbioCaymanProbio Cayman150.0Probio CaymanProbio125.0Probio Cayman Probio CaymanProbio Cayman319,998,370Probio Cayman CProbio C224.0Probio C Probio AProbio CProbio Probio AProbio CProbio428.351.0 Probio CaymanProbio Cayman57,314,000Probio Cayman BProbio Cayman B37.3Probio BProbio B ProbioCayman B 2023012 37,609,0705.3250.035.210.4168%AA A Probio B1.6ProbioB37.91.1A34.5 3.81.1 245.8233.6162.0 14941.925.527.2 335.3146.9 0.953.080.2 1.4%5.2%11 (i)(ii) 2023014 —12100%34 140.0A-AA-A1 5.2% 260.0AAAmAaa-mfAAAmmf362.0463.0AAAmAaa-mf 22SEC19402a-7 3319402a-7 44SEC19402a-7 2341.00 *AB 161414.071.0% 3.80.3 2023016 Probio Cayman Probio CaymanProbio Cayman319,998,370Probio C224.0Probio C Probio CaymanProbio Cayman 37,609,0705.3250.035.210.4168%A (i)26.127,656,968(ii)26.12484,992(iii)64.005,468,75010,937,500(iv)32.00692,782 GenScript Japan Inc.GS40.0277,000(TIBOR)0.25%GSGS GS22.03.02.6%GS GS26.33.61.4%GS85.011.82.5%2.6%GS 119.116.51.3% 250.017.353.149.35.360.960.53.620.6 (LIBOR)2.5% 2023018 128.2GS40.0277,000 400,00020.15.0 239.633.2BProbioCayman 5.63.238.4%46.5% 30 CGTGMP GMPGMP CARVYKIMM IT 44.822.0 2023020 243.5 500.6 Probio CaymanProbio Cayman319,998,370C224.0Probio C 26.127,656,968 26.12484,99232.00692,782 64.005,468,750 LGN Holdings Limited10,000,00020.00200.0LGNHoldings Limited10,000,000 2023022 37,609,070250.010.4168%A CARVYKTI II15.020.0 CGTCAR-TCGTCGT 20100 CDMOCDMOCDMO IITIIT 6,414 260.966.7% 2023024 XVXV7835210 (1)Genscript CorporationGS Corp5.11%GS CorpGS Corp41,401,870GS Corp20,700,935GS Corp (2)20,700,935GS Corp2,361,100GSCorpGS Corp21.34%GS Corp4.60% (3)240,0001,843,320232,573 (4)GS Corp3.79%GS CorpGS Corp (5)GS CorpGSCorpGS Corp808,577,123GSCorp108,625,000GSCorp (6)180,00038,150,000138,630 (7)863,820GS CorpGS Corp8.42%638,000Ren-Shiu Foundation Inc. (8)180,000634,0001,269,674 (9)GS Corp22.76%GS CorpGS Corp 2023028 (10)HuangLiliHuangLili638,000(11)14,929460,000(12)14,929270,000(13)14,929460,000(14)14,929439,000(15)14,929270,000(16)210,000(17)3,442,766101,3452,000,000409,854(18)4,502,7755,000,000135,897 XV(i)352(ii) XV23336 2023030 (1)GSCorp22A4L4443B5.11%21.34%4.60%4.60%4.60%22.76%0.12%3.80%3.72%3.72%4.86%6.44%3.79%8.42%1.05%1.07% (2)GS Corp21.34%GS CorpGS Corp4.60%4.60% (3)GS Corp8.42%GS Corp (4)11,583,632GS Corp14,829,15014,859,54514,859,545GSCorpAL29,000,000GS Corp (5)Huang Lili638,000Huang LiliHuang Lili (6)GNS Holdings LimitedHillhouse Investment Management V, Ltd.Hillhouse FundV, L.P.GNS Holdings Limited XV23336 2023031 74,6451,002,3436,315,784 2,619,525965,1555,072,636 3,584,680A20%A 5,072,636B423,611,70520%B418,539,069 8,657,3162,106,881,5640.41% Probio CaymanProbio CaymanProbio17.14Probio CaymanProbio17 2023032 1.19.522.25 17 80,374,20081,535,855 17 1.23.52 2.25 2023038 (i)(ii)(iii) 183,721,269 (i)(ii) 74,6451,002,3436,315,784 26 (1)(2)17.95(3)(i)(ii)(4)(i)(ii)(5)(i)(ii)(6)(i)(ii)(7) 2023042 (i)(ii) (i)(ii)(iii) 183,721,269 (i)(ii) 2,619,525965,1555,072,63626 2023044 (1)(2)18.93(3)(i)(ii)(4)(i)(ii)(5)(6) 2023045 167,667,287152,369,874 17 1818 25% GNS Holdings LimitedGNS18.658102,981,85319247.9 2023046 10 14 2023 (i)(ii)(iii) (1)572,000 2023048 (2)465,139(3)668,109(4)290,464 13.51B(1) Genscript Biotech (Spain), S.L. ADAG (i)600079(ii) 13.51(2)(a)(e)(g)13.51B(1) Tel䴱䂧: +852 2846 9888Fax۩ⵕ: +852 2868 4432ey.com ᆿ≮ᴹ䀾ᑡӁएᡶ俏⑥券冐⏂㤧ⲽ䚉㲕འਚ඀жᓝ⁉ Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 50112343434 2410 34 1.